Cholesterol crystallization-promoters in human bile: comparative potencies of immunoglobulins, alpha 1-acid glycoprotein, phospholipase C, and aminopeptidase N1.
Concanavalin A (Con A)-binding glycoproteins accelerate the rate of cholesterol crystal formation as a prelude to gallstone formation. Immunoglobulins (IgM, IgA, and IgG), aminopeptidase N (APN), phospholipase C (pcPLC), and alpha 1-acid glycoprotein from this Con A fraction have all been proposed as candidate promoters. We immunopurified each of the six putative promoters and examined their comparative effects by adding equal amounts to a cholesterol crystal growth assay. The effects of immunoabsorptive removal of each of the specific candidate promoters from native bile were also compared. In additional studies, the potency of these proteins was in the following order: IgM > IgA = AAG > IgG. APN and pcPLC showed no effect on cholesterol crystal growth at their apparent physiological concentrations. In subtractive experiments, only a minor loss (< 10%) of net promoting activity from that of the whole Con A-bound fraction was observed after immunoabsorptive removal of pcPLC, APN, or immunoglobulins. Total removal of AAG, however, showed a far greater loss (/33%) of the net promoting activity. These data indicate that AAG accounts for the greatest portion of net biliary Con A-bound promoting activity derived from currently defined and well-identified glycoproteins. However, more than 60% of total Con A-binding promoting activity remains unaccounted for, indicating the presence of other important and still unidentified promoters in human bile.
Abei
M
M
Gastrointestinal Research Unit, Cleveland Clinic Foundation, OH 44195-5218.
Schwarzendrube
J
J
Nuutinen
H
H
Broughan
T A
TA
Kawczak
P
P
Williams
C
C
Holzbach
R T
RT
D000626:Aminopeptidases / Q000737:chemistry*; D001646:Bile / Q000737:chemistry*; D018826:CD13 Antigens; D005591:Chemical Fractionation; D002769:Cholelithiasis / Q000378:metabolism; D002784:Cholesterol / Q000737:chemistry*; D003208:Concanavalin A / Q000737:chemistry; D003460:Crystallization; D006801:Humans; D007136:Immunoglobulins / Q000737:chemistry*; D007163:Immunosorbent Techniques; D009961:Orosomucoid / Q000737:chemistry*; D010738:Type C Phospholipases / Q000737:chemistry*
D007136:Immunoglobulins; D009961:Orosomucoid; D003208:Concanavalin A; D002784:Cholesterol; D010738:Type C Phospholipases; D000626:Aminopeptidases; D018826:CD13 Antigens